Skip to main content
Journal cover image

Antibiotic Duration after Debridement and Implant Retention for Early Postoperative Spinal Implant Infections: A Multicenter Cohort Study.

Journal articles  - Journal Article
Tai, DBG; Poehlein, E; O'Neil, JC; Nelson, SB; Tande, AJ; Corvino, DDL; Ritter, AS; Aronson, J; Certain, L; Furukawa, D; Tatara, AM; Green, CL ...
Published in: Clin Infect Dis
May 5, 2026

BACKGROUND: Postoperative spinal implant infections (PSII) are a serious complication of instrumented spinal fusion. Although debridement with implant retention is standard for early infection, the optimal duration of antimicrobial therapy remains uncertain. METHODS: We conducted a multicenter retrospective cohort study across ten U.S. academic centers, including adults with early PSII (≤90 days after fusion surgery) from 2017 to 2021. We excluded patients who experienced treatment failure within 6 weeks of debridement. The primary outcome was treatment failure. Antibiotic therapy effect was analyzed as a time-varying exposure using adjusted Cox proportional hazards models. Secondary analyses included 12-week landmark and clone-censor-weighted models to compare durations ≤12 weeks versus >12 weeks. RESULTS: 116 patients out of 499 (23.2%) experienced treatment failure during a median follow-up of 3.2 years. Among patients who remain failure-free six weeks from debridement, being on antibiotics was not associated with treatment failure (adjusted hazard ratio [aHR] 0.71, 95% confidence interval [CI] 0.48-1.07; p = 0.10). In a 12-week landmark analysis limited to 359 patients who were not on indefinite suppressive antibiotic therapy, treatment durations >12 weeks did not significantly reduce the risk of failure (aHR 1.01, 95% CI 0.62-1.64; p = 0.99). Results were consistent in the clone-censor-weight sensitivity analysis (aHR 0.85, 95% CI 0.62-1.16; p = 0.30). CONCLUSIONS: Prolonged antibiotic therapy was not associated with improved outcomes in early PSII managed with debridement and implant retention. These results support shorter, individualized antibiotic courses in patients with adequate surgical source control.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Clin Infect Dis

DOI

EISSN

1537-6591

Publication Date

May 5, 2026

Location

United States

Related Subject Headings

  • Microbiology
  • 3202 Clinical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Tai, D. B. G., Poehlein, E., O’Neil, J. C., Nelson, S. B., Tande, A. J., Corvino, D. D. L., … SPIRIT Team. (2026). Antibiotic Duration after Debridement and Implant Retention for Early Postoperative Spinal Implant Infections: A Multicenter Cohort Study. Clin Infect Dis. https://doi.org/10.1093/cid/ciag300
Tai, Don Bambino Geno, Emily Poehlein, Jessica C. O’Neil, Sandra B. Nelson, Aaron J. Tande, Daniela De Lima Corvino, Alaina S. Ritter, et al. “Antibiotic Duration after Debridement and Implant Retention for Early Postoperative Spinal Implant Infections: A Multicenter Cohort Study.Clin Infect Dis, May 5, 2026. https://doi.org/10.1093/cid/ciag300.
Tai DBG, Poehlein E, O’Neil JC, Nelson SB, Tande AJ, Corvino DDL, et al. Antibiotic Duration after Debridement and Implant Retention for Early Postoperative Spinal Implant Infections: A Multicenter Cohort Study. Clin Infect Dis. 2026 May 5;
Tai, Don Bambino Geno, et al. “Antibiotic Duration after Debridement and Implant Retention for Early Postoperative Spinal Implant Infections: A Multicenter Cohort Study.Clin Infect Dis, May 2026. Pubmed, doi:10.1093/cid/ciag300.
Tai DBG, Poehlein E, O’Neil JC, Nelson SB, Tande AJ, Corvino DDL, Ritter AS, Aronson J, Certain L, Furukawa D, Tatara AM, Green CL, Abdalla T, Fleece ME, Tobert DG, Erickson M, Seidelman J, SPIRIT Team. Antibiotic Duration after Debridement and Implant Retention for Early Postoperative Spinal Implant Infections: A Multicenter Cohort Study. Clin Infect Dis. 2026 May 5;
Journal cover image

Published In

Clin Infect Dis

DOI

EISSN

1537-6591

Publication Date

May 5, 2026

Location

United States

Related Subject Headings

  • Microbiology
  • 3202 Clinical sciences